Dariohealth Corp Stock Price, News & Analysis

DarioHealth Corp. (Nasdaq: DRIO) announced a strategic partnership with a national benefits administrative platform to deliver its digital therapeutic solutions, beginning January 2022. This collaboration aims to provide integrated chronic condition management solutions, including diabetes and hypertension, to a broad employer base. Dario's platform focuses on improving health outcomes and lowering costs for users through an AI-driven journey engine, enhancing accessibility in seven languages. This partnership is expected to expand Dario's visibility among employers seeking scalable health solutions.

DarioHealth Corp. (Nasdaq: DRIO) has secured contracts with two regional providers in Hawaii and Georgia for its Remote Patient Monitoring (RPM) services, enhancing its presence in the RPM market. These agreements focus on managing diabetes and hypertension, addressing common chronic conditions. Dario currently supports over 197,000 members on its digital therapeutics platform, showcasing its credibility among providers. The company's innovative platform offers personalized solutions, appealing to healthcare providers seeking effective patient engagement.

DarioHealth has partnered with Virgin Pulse to provide its digital therapeutic solutions to global employers and health plans. This collaboration allows eligible employees to access Dario's services through Virgin Pulse's Homebase for Health® platform. The integrated solutions support various chronic conditions, utilizing AI and extensive user data for personalized health management. Virgin Pulse aims to enhance member health outcomes by simplifying access to Dario's services, which are expected to decrease healthcare costs and improve clinical results.

DarioHealth Corp. (Nasdaq: DRIO) recently launched Dario Move, a new digital physical therapy solution aimed at managing musculoskeletal (MSK) conditions. This innovative product was presented at HLTH 2021 in Boston. The solution integrates advanced sensor technologies to provide personalized exercise programs and real-time coaching, enhancing accessibility to treatment. With 50% of U.S. adults affected by MSK disorders, Dario Move aims to reduce care costs and improve patient engagement. The company highlights the growing need for such digital therapies in an increasingly expensive healthcare landscape.

DarioHealth Corp. (Nasdaq: DRIO) has entered an agreement with a major U.S. national health plan to provide its digital behavioral health solution to self-insured employers. Initial member access is expected in Q4 2021, with wider rollout in 2022. Dario will earn a monthly fee for each member. This partnership aims to enhance mental health care access and improve member experience through AI-driven personalized care options. The agreement could generate millions in annual revenue and signifies potential for further opportunities with this client.

DarioHealth Corp. (Nasdaq: DRIO) will participate in a fireside chat at the Cantor Fitzgerald Virtual Global Healthcare Conference from September 27-30, 2021. The management's presentation is scheduled for Thursday, September 30, 2021, at 8:40 AM ET. Interested parties can register for the live webcast here. DarioHealth is recognized for its digital therapeutic solutions that enhance chronic condition management.

DarioHealth Corp. (Nasdaq: DRIO) announces that Chief Medical Officer, Dr. Omar Manejwala, will present at the American Health Insurance Plans' National Conference on Medicare, Medicaid, and Dual Eligibles on September 22, 2021, at 12:45 p.m. EST. His presentation will focus on the role of digital therapeutics in addressing health disparities among Medicaid populations. Dr. Manejwala emphasizes the need for tailored digital solutions to improve access and health outcomes for underserved groups, highlighting significant growth in digital health during the pandemic.